Have a feature idea you'd love to see implemented?
Let us know!
ARVN Arvinas Inc
Price (delayed)
$24.96
Market cap
$1.71B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$5.29
Enterprise value
$1.56B
Arvinas is a clinical-stage biopharmaceutical company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing
Highlights
The debt has dropped by 53% year-on-year and by 19% since the previous quarter
The company's equity rose by 29% YoY
The gross profit has contracted by 41% YoY but it has grown by 31% from the previous quarter
Arvinas's revenue has decreased by 41% YoY but it has increased by 31% from the previous quarter
Key stats
What are the main financial stats of ARVN
Market
Valuations
Earnings
Shares outstanding
68.65M
Market cap
$1.71B
Enterprise value
$1.56B
Price to earnings (P/E)
N/A
Price to book (P/B)
2.85
Price to sales (P/S)
19.23
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
16.67
Revenue
$93.3M
EBIT
-$321.5M
EBITDA
-$314.7M
Free cash flow
-$217M
Per share
Balance sheet
Liquidity
EPS
-$5.29
Free cash flow per share
-$3.02
Book value per share
$8.77
Revenue per share
$1.3
TBVPS
$17.8
Total assets
$1.28B
Total liabilities
$679.4M
Debt
$2.1M
Equity
$600.2M
Working capital
$909.5M
Debt to equity
0
Current ratio
3.62
Quick ratio
3.58
Net debt/EBITDA
0.5
Margins
Efficiency
Dividend
EBITDA margin
-337.3%
Gross margin
100%
Net margin
-346.6%
Operating margin
-397.6%
Return on assets
-26.6%
Return on equity
-55.6%
Return on invested capital
-42.7%
Return on capital employed
-34.5%
Return on sales
-344.6%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ARVN stock price
How has the Arvinas stock price performed over time
Intraday
1.96%
1 week
0.89%
1 month
-0.68%
1 year
38.05%
YTD
-39.36%
QTD
1.34%
Financial performance
How have Arvinas's revenue and profit performed over time
Revenue
$93.3M
Gross profit
$93.3M
Operating income
-$371M
Net income
-$323.4M
Gross margin
100%
Net margin
-346.6%
Arvinas's operating margin has plunged by 108% YoY but it has increased by 29% from the previous quarter
The net margin has dropped by 84% year-on-year but it rose by 30% since the previous quarter
The gross profit has contracted by 41% YoY but it has grown by 31% from the previous quarter
Arvinas's revenue has decreased by 41% YoY but it has increased by 31% from the previous quarter
Growth
What is Arvinas's growth rate over time
Valuation
What is Arvinas stock price valuation
P/E
N/A
P/B
2.85
P/S
19.23
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
16.67
The EPS has grown by 13% from the previous quarter and by 5% YoY
The stock's price to book (P/B) is 38% less than its 5-year quarterly average of 4.6 and 14% less than its last 4 quarters average of 3.3
The company's equity rose by 29% YoY
The P/S is 63% below the 5-year quarterly average of 52.0 and 21% below the last 4 quarters average of 24.4
Arvinas's revenue has decreased by 41% YoY but it has increased by 31% from the previous quarter
Efficiency
How efficient is Arvinas business performance
The ROS has plunged by 91% YoY but it has grown by 30% from the previous quarter
The company's return on invested capital fell by 23% YoY but it rose by 12% QoQ
ARVN's return on equity is up by 14% since the previous quarter
ARVN's return on assets is up by 13% since the previous quarter but it is down by 9% year-on-year
Dividends
What is ARVN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ARVN.
Financial health
How did Arvinas financials performed over time
ARVN's total assets is 88% more than its total liabilities
ARVN's current ratio is down by 27% QoQ but it is up by 5% YoY
The quick ratio has declined by 27% since the previous quarter but it is up by 4.7% year-on-year
The debt is 100% smaller than the equity
The debt to equity has plunged by 100% YoY
The debt has dropped by 53% year-on-year and by 19% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.